Document Detail


Acute and chronic effects of dexfenfluramine on the porcine coronary artery.
MedLine Citation:
PMID:  8968327     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Experiments were designed to verify whether or not acute or chronic exposure to dexfenfluramine favors the occurrence of coronary vasospasm in vivo or in vitro. Rings of left anterior and left circumflex porcine coronary artery, with and without endothelium, were studied in conventional organ chambers for the measurement of isometric force. The donor pigs were divided into two groups: controls and animals fed for 4 weeks with dexfenfluramine. In each group, one-half of the animals underwent balloon denudation of the left anterior descending coronary artery at the beginning of the study. Coronary angiography was performed at the time of denudation and, in all animals, during the 3rd week of the study. Acutely, dexfenfluramine at concentrations higher than 10(-5) M caused contractions which were blunted by the presence of the endothelium and inhibited by indomethacin (an inhibitor of cyclooxygenase). Chronic treatment with dexfenfluramine did not affect coronary diameter and did not alter the response to intracoronary infusion of serotonin. Chronic treatment with dexfenfluramine reduced the contractions of rings without endothelium to serotonin, but not those to norepinephrine or endothelin. It did not affect endothelium-dependent relaxations in the absence or presence of pertussis toxin to serotonin, UK14304 (alpha-2 adrenergic agonist), adenosine diphosphate or aggregating platelets. Chronic treatment with dexfenfluramine did not modify relaxations of rings without endothelium to SIN-1 (nitric oxide donor; the active metabolite of molsidomine) or adenosine diphosphate. These findings do not support the hypothesis that acute or chronic exposure to dexfenfluramine favors the occurrence of coronary vasospasm.
Authors:
B Desta; D Schultz; D Ravel; N Laudignon; P M Vanhoutte; C M Boulanger
Related Documents :
9249237 - Neocuproine, a selective cu(i) chelator, and the relaxation of rat vascular smooth musc...
7400317 - Supersensitivity of atherosclerotic rabbit aorta to ergonovine. mediation by a serotone...
10925237 - The action of diaspirin cross-linked haemoglobin blood substitute on human arterial byp...
3165267 - Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative...
19633027 - Failure to exclude a saccular arch aneurysm during hybrid repair: arch replacement with...
23506637 - Mechanisms of oxidative stress in human aortic aneurysms - association with clinical ri...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  279     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1996 Dec 
Date Detail:
Created Date:  1997-01-23     Completed Date:  1997-01-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1077-85     Citation Subset:  IM    
Affiliation:
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Body Weight
Coronary Vessels / drug effects*
Fenfluramine / pharmacology*
Male
Platelet Aggregation / drug effects
Serotonin / pharmacology
Swine
Vasoconstrictor Agents / pharmacology*
Vasodilator Agents / pharmacology
Chemical
Reg. No./Substance:
0/Vasoconstrictor Agents; 0/Vasodilator Agents; 458-24-2/Fenfluramine; 50-67-9/Serotonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SN...
Next Document:  The basolateral organic cation transport system of rabbit kidney proximal tubules. Influence of anor...